Sol-Gel Technologies Shares Outstanding 2016-2018 | SLGL

Current and historical number of shares outstanding for Sol-Gel Technologies (SLGL) from 2016 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Sol-Gel Technologies Annual Shares Outstanding
(Millions of US $)
2017 $6
2016 $6
2015 $6
Sol-Gel Technologies Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $19
Q1 2018 $15
Q4 2017 $0
Q3 2017 $0
Q2 2017 $6
Q4 2016 $0
Q4 2015 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.118B $0.000B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $62.621B 10.74
Teva Pharmaceutical Industries (TEVA) Israel $22.849B 6.38
Mylan (MYL) United Kingdom $19.499B 8.29
Bausch Health Cos (BHC) Canada $7.285B 5.44
Dr Reddy's Laboratories (RDY) India $5.340B 23.85
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.698B 4.59
Akorn (AKRX) United States $2.422B 11.99
Supernus Pharmaceuticals (SUPN) United States $2.258B 24.16
Assembly Biosciences (ASMB) United States $0.913B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.809B 116.67
CymaBay Therapeutics (CBAY) United States $0.706B 0.00
Homology Medicines (FIXX) United States $0.622B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.604B 0.00
Voyager Therapeutics (VYGR) United States $0.593B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.590B 0.00
Corium (CORI) United States $0.319B 0.00
Teligent (TLGT) United States $0.225B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.111B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.067B 0.00
Aevi Genomic Medicine (GNMX) United States $0.066B 0.00
Versartis (VSAR) United States $0.062B 0.00
Evoke Pharma (EVOK) United States $0.039B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.022B 0.00
Acasti Pharma (ACST) Canada $0.017B 0.00
China Pharma Holdings (CPHI) China $0.010B 0.00
Agile Therapeutics (AGRX) United States $0.009B 0.00